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Ultraviolet radiation (UVR) damages the dermis and fibroblasts; and increases melanoma
incidence. Fibroblasts and their matrix contribute to cancer, so we studied how UVR modifies
dermal fibroblast function, the extracellular matrix (ECM) and melanoma invasion. We
confirmed UVR-damaged fibroblasts persistently upregulate collagen-cleaving matrix
metalloprotein-1 (MMP1) expression, reducing local collagen (COL1A1), and COL1A1 degra-
dation by MMP1 decreased melanoma invasion. Conversely, inhibiting ECM degradation and
MMP1 expression restored melanoma invasion. Primary cutaneous melanomas of aged
humans show more cancer cells invade as single cells at the invasive front of melanomas
expressing and depositing more collagen, and collagen and single melanoma cell invasion are
robust predictors of poor melanoma-specific survival. Thus, primary melanomas arising over
collagen-degraded skin are less invasive, and reduced invasion improves survival. However,
melanoma-associated fibroblasts can restore invasion by increasing collagen synthesis.
Finally, high COL1A1 gene expression is a biomarker of poor outcome across a range of
primary cancers.
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UVR is the major environmental risk factor for the devel-opment of melanoma1–5 and sun exposure is the maincause of rising disease incidence3. While the association
between UVR and melanoma incidence is well established5, there
are controversial clinical studies associating sun exposure, or sun
damage to the dermis, with improved melanoma survival6–8.
However, other studies have found no association between sun
damage and outcome, and clinical studies show melanomas
arising on the scalp and neck, areas likely chronically sun
damaged, are linked to poor outcome9–11.
UVR damage accumulates with increasing decades of life, and
aged patients have worse melanoma survival12–15. Therefore, it is
possible that chronic UVR damage may lead to shorter
melanoma-specific survival (MSS). However, in common with
some non-hormonal cancers, the incidence and mortality of
melanoma sharply rise after age 60, and then significantly
decrease after age 85 (refs. 16,17), suggesting the relationship
between cumulative UVR exposure, cutaneous damage, age and
melanoma death is not linear.
Previous studies have shown collagen quantity in the extra-
cellular matrix (ECM) modifies melanoma cell behaviour18.
Surprisingly, both increased19 and decreased20 deposition of
collagen have been linked to malignant behaviour, suggesting the
effect of collagen on cancer behaviour extends beyond protein
level and scaffold function. In this study, we explore how collagen
levels in the dermis, which vary according to sun damage and age,
affect melanoma survival.
Results
Somatic mutation burden in dermal fibroblasts correlates with
extracellular matrix degradation and collagenase expression.
The pivotal task of dermal fibroblasts is to regulate ECM remo-
delling, including the turnover of collagen21. In chronically UVR-
damaged skin there is an increase of mutations22 and degraded
collagen that is not compensated by new collagen synthesis, con-
tributing to overall ECM degradation. We analysed gene expression
in human adult fibroblasts to compare matched UVR-damaged and
UVR-protected dermis from healthy donors (median age 42, range
19–66, ref. 23). We used COSMIC total signature 7 mutations24,
which indicate UVR-induced damage, as a surrogate marker of
accumulated UVR exposure. Strikingly, the most significantly dif-
ferentially expressed pathway was the ECM pathway (Fig. 1a, b,
Supplementary Data 1 and Supplementary Table 1), demonstrating
progressive downregulation of collagen genes (Supplementary
Table 2) and upregulation of matrix metalloproteinases (MMP),
including matrix metalloproteinase-1 (MMP1), in UVR-damaged
adult donor fibroblasts, with increasing signature 7 mutations.
Furthermore, MMP1 was highly expressed in donor fibroblasts
from UVR-exposed calves of adults in the Genotype-Tissue
Expression cohort25 (median TPM= 51.85, n= 504, median all
tissues TPM= 0.078).
MMP1 cleaves collagen 1 (COL1A1) after acute UVR
exposure26,27, so we compared the secretion of MMP1, COL1A1
expression and ECM collagen deposition of isogenic UVR-naive
fibroblasts from a human foreskin fibroblast cell line (HFF) and
UVR-damaged fibroblasts (UV-HFF) 2 weeks after UVR
exposure (Supplementary Fig. 1a). We found UV-HFF fibro-
blasts increased the secretion of MMP1 (Supplementary Fig. 1b)
with no compensatory increase in COL1A1 transcription
(Supplementary Fig. 1c) or deposition in the ECM of UV-
HFF, compared to UVR-naive fibroblasts (COL1A1 mean label-
free quantification (LFQ) intensity HFF= 33.20, UV-HFF=
33.47, q value= 0.16, COL1A2 HFF= 32.57, UV-HFF= 32.87,
q value= 0.08, Supplementary Fig. 1d). In addition, atomic
force microscopy (AFM) topographic imaging suggested
UV-HFF fibroblast-generated ECM presented more fragmen-
ted, sparser and disorganised matrix fibrils than UVR-naive,
HFF fibroblasts. The higher roughness (Rq) value indicates less
symmetry across the ECM surface plane, in keeping with
degradation of UV-HFF fibroblast-generated ECM28–30 (Fig. 1c,
d). Furthermore, immunofluorescent staining of fibronectin
fibres in HFF and UV-HFF-derived ECM, confirmed that UV-
HFF matrices were significantly more disorganised with fewer
aligned fibres than matrices generated by HFF fibroblasts
(Fig. 1e–g).
Since UVR damage alters fibroblast function, compromising
ECM renewal, we compared the density of collagen fibres in
chronically sun-damaged and sun-protected healthy skin of aged
patients (n= 16, age > 59); confirming reduction of collagen in
UVR-damaged dermis31 (Fig. 1h). In addition, we confirmed
fibroblasts from tumour-adjacent sun-damaged patient dermis
(solar elastosis31,32) have higher total somatic mutation burden22
(n= 13, Fig. 1i), indicating that cumulative UVR leads to dermal
ECM degradation and decreased collagen.
Low collagen concentration and reduced collagen integrity
decrease melanoma invasion. To study if UVR damage to
fibroblasts driving collagen degradation affects melanoma
progression, we compared melanoma invasion in spheroids
embedded in matrices of increasing collagen concentrations.
Melanoma cell lines present varying degrees of invasion, so we
used three cell lines established from tumours bearing different
UVR mutation signatures, reflecting UVR and non-UVR
tumour origins33 (Supplementary Fig. 2a). We found that
regardless of the UVR history of the melanoma cell line, the
invasion of the three melanoma lines was optimal in 1.5 mg/ml
collagen, and higher (2.5 mg/ml, p < 0.0001) and lower collagen
concentrations significantly reduced invasion into the ECM
(0.25 mg/ml, p < 0.0001, 0.5 mg/ml, p= 0.03; Fig. 2a, b and
Supplementary Fig. 2b). In addition, we quantified the number
of melanoma cells detaching from the spheroid and invading as
single cells, and found single cell invasion optimal within a
range of collagen concentrations, decreasing with higher and
lower collagen densities (Fig. 2c, d). We generated organotypic
dermal constructs with HFF or UV-HFF foreskin human
fibroblasts, seeded with melanoma cell lines (Fig. 2e and Sup-
plementary Fig. 2c), and confirmed UV-HFF constructs pre-
sented fewer melanoma cells detaching from the tumour edge,
singly advancing in the dermis (Sk-mel-28 p= 0.04; Fig. 2f).
UV-HFF constructs replicated the cardinal features of UVR
damage34–36, with significantly reduced collagen levels com-
pared to HFF constructs (p < 0.0001, Supplementary Fig. 2d, e).
In addition, UV-HFF constructs presented reduced fibronectin
(Supplementary Fig. 2f), and no difference in elastin expression
compared to HFF constructs (Supplementary Fig. 2g). These
data indicate that melanoma invasion is optimal within a range
of collagen concentrations. Critically, lower collagen con-
centrations limit melanoma invasion.
Since UVR compromises collagen integrity indirectly by
damaging fibroblasts (Fig. 1), we exposed melanoma spheroids,
embedded in equal concentrations of collagen matrices, to
increasing concentrations of the enzyme collagenase I to mimic
the effects of UVR exposure (Supplementary Fig. 2h). We found
that melanoma invasion and single cell invasion significantly
decreased in matrices exposed to higher doses of collagenase I
(5 µg/ml, p= 0.0005, 10 µg/ml, p < 0.0001; Fig. 2g–j and Supple-
mentary Fig. 2i). These data show that collagen quantity and
degraded collagen limit melanoma invasion.
To explore if adult fibroblasts regulate collagen degradation
and melanoma invasion, we harvested adult dermal fibroblasts
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from different anatomic sites from tumour-adjacent normal skin
of eight patients and established cells lines (Supplementary
Table 3, age median 69, range 34–77). We confirmed the patient
dermal fibroblasts express and secrete varying levels of MMP1
(Supplementary Fig. 2j, k), and embedded melanoma spheroids in
matrices of collagen mixed with the donor fibroblast secretome.
We found melanoma spheroids were less invasive in matrices
containing patient fibroblast secretomes with higher amounts of
MMP1 (Fig. 2k). Importantly, COL1A1 expression correlated
strongly with melanoma invasion, (Sk-mel-28 p= 0.02, R= 0.32,
Fig. 2l). Finally, we confirmed that human fibroblasts, and not
melanoma cells, are the main source of MMP1; and the
melanoma cell lines do not express COL1A1 or COL1A2
(ref. 37, Supplementary Fig. 2l). Taken together, these data
demonstrate human adult fibroblasts modulate collagen biology
and melanoma invasion.
Inhibition of MMP1 restores melanoma invasion. We studied if
adult human fibroblasts from distinct anatomic sites affect the
ECM and melanoma invasion differentially, and established
fibroblast lines from chronic sun-damaged (CSD) and
sun-protected, or non-sun damaged (noCSD) tumour-adjacent
skin32 of two patients (age CSD= 77, age noCSD= 46). Donor
fibroblasts were exposed to low doses of UVB (8 × 100 J/m2) to
generate isogenic pairs of noCSD and noCSD-UV fibroblasts,
CSD and CSD-UV fibroblasts and allowed 14 days recovery
(Supplementary Fig. 2m). We confirmed noCSD-UV fibroblasts
robustly increased MMP1 expression (fold change= 2.03, p=
0.002) and secretion (median MMP1: noCSD= 6858 pg/ml,
noCSD-UV= 13,292 pg/ml, fold change= 1.98, p= 0.03) com-
pared to noCSD donor fibroblasts (Fig. 3a, b); and CSD-UV
fibroblasts weakly upregulated MMP1 expression (fold change=
1.46, p= 0.39), and secretion (median MMP1: CSD= 9066 pg/
ml, CSD-UV= 13051 pg/ml, fold change= 1.49, p= 0.03).
Importantly, noCSD-UV and CSD-UV fibroblasts did not
increase COL1A1 expression (Supplementary Fig. 2n). We then
compared the effect of the fibroblast secretomes on melanoma
spheroid invasion in the presence or absence of the MMP inhi-
bitor Batimastat, which directly blocks the activity of MMPs.
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Fig. 1 UVR-driven mutations in adult donor dermal fibroblasts correlate with ECM degradation and collagenase expression. a Volcano plot gene
expression and b extracellular matrix (ECM) heatmap by COSMIC signature 7 mutations in skin fibroblasts23. Colour scale: red upregulated, blue
downregulated genes, sample clustered by signature 7 mutations: colour scale 0 (white) to 112 (green), red box: genes upregulated with signature 7
mutations. c Atomic force microscopy (scale: 5 µm, height colour scale −115 (dark brown), 115 (white)), and d matrix roughness (Rq) of in vitro ECM of
HFF and UV-HFF, two-sided Mann–Whitney U *p= 0.0286, data represents two measurements from two biologically independent cell lines per condition.
e Quantification of fibre alignment distribution in human foreskin fibroblasts HFF and UV-HFF-derived ECM by fibronectin immunofluorescence. f Fraction
of fibres within 10° of mode orientation, two-sided Mann–Whitney U **p= 0.0022, data represents two biologically independent cell lines three fields of
view per condition. g Immunofluorescence of fibronectin fibres in decellularised HFF and UV-HFF-derived ECM, colour coded for orientation of fibre, cyan
represents mode, red ±90°, scale bar: 25 µm. hMasson’s trichrome collagen stain of sun-protected (n= 9, noCSD) and sun-damaged (n= 7, CSD) dermis,
two-sided Mann–Whitney U ****p < 0.0001. i Correlation between SNV load and solar elastosis in fibroblasts, blue: CSD, pink: noCSD, two-sided Spearman
correlation R= 0.40, p= 0.2, n= 13 biologically independent samples. Error bars: standard error of the mean (bar).
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Consistent with a higher MMP1 expression, the noCSD-UV
secretome significantly decreased melanoma invasion compared
to the noCSD secretome (p= 0.001), and importantly, Batimastat
restored melanoma cell invasion (p= 0.01; Fig. 3c). Intriguingly,
UVR damage or Batimastat treatment of the CSD fibroblast
model (CSD-UV) only slightly modulated melanoma invasion
(Fig. 3d), possibly indicating the effect of UVR damage to
fibroblasts and MMP1 expression is capped, and higher doses of
MMP inhibition are required in highly expressing MMP1, CSD-
UV fibroblasts.



























































0.5 mg/ml 1 mg/ml 1.5 mg/ml 2 mg/ml 2.5 mg/ml


























































































































































Patient dermal fibroblasts secretome Patient dermal fibroblasts







p = 0.1 R = -0.39
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Since MMP1 specifically cleaves COL1A1 (ref. 26), we
generated isogenic shCtrl-HFF, shCtrl-UV-HFF, shMMP1-HFF
and shMMP1-UV-HFF lines from HFF to compare collagen
degradation in the absence of acute UVR exposure (Supplemen-
tary Fig. 3b, c). In keeping with a higher expression of MMP1,
shCtrl-UV-HFF fibroblasts degraded more collagen, while
shMMP1-UV-HFF did not increase collagen degradation com-
pared to shMMP1-HFF fibroblasts (Fig. 3e, f). The specific role of
MMP1 was validated with an additional knockdown with an
siRNA targeting MMP1 (Supplementary Fig. 3d–f). In addition,
we found shRNA targeting MMP2 did not modify collagen
degradation (Supplementary Fig. 3b, g, h); and knockdown of
MMP1 restored the alignment of fibres in UV-HFF matrices
(Fig. 3g, h and Supplementary Fig. 3i). Furthermore, organotypic
invasion assays with matrices generated with shCtrl-HFF, shCtrl-
UV-HFF, shMMP1-HFF or shMMP1-UV-HFF fibroblasts,
showed melanoma invasion was decreased in the shCtrl-UV-
HFF constructs (p= 0.03), and not in shMMP1-HFF or
shMMP1-UV-HFF fibroblast matrices (Fig. 3i, j). Knockout of
MMP1 restored collagen and fibronectin levels in UV-HFF
constructs to similar levels as HFF (Supplementary Fig. 3j, k, l and
see also Supplementary Fig. 2c, d, f). Altogether, these data
demonstrate fibroblast-secreted MMP1 degrades collagen, limit-
ing melanoma invasion.
Collagen degradation decreases primary melanoma invasion
and improves survival. If the amount and integrity of collagen
restricts single cell invasion, patients with primary cutaneous
melanoma invading in a less collagenous dermis should live
longer than patients with more dermal collagen. Compared to
young fibroblasts and dermis, aged and UVR-protected fibro-
blasts in an aged ECM drive melanoma invasion and
metastasis38,39, so we restricted our study to three international
cohorts of older primary cutaneous melanoma patients (Supple-
mentary Table 4). We determined the proportion of melanoma
cells invading in the ECM at the invasive front (IF), the amount
of collagen and the degree of ECM degradation (solar elastosis) in
tumour-adjacent dermis (Fig. 4a and Supplementary Fig. 4a). We
found patient samples with more solar elastosis (less collagen in
tumour-adjacent skin), had fewer invading cells at the IF (Fisher
exact test, p= 2.25 × 10−5 Fig. 4b, Supplementary Fig. 4b and
Supplementary Data 2). Critically, MSS was significantly
improved in patients with less invasion in multivariate analyses
(Fig. 4c, Supplementary Fig. 4c, d and Supplementary Table 5).
Intriguingly, solar elastosis was not as powerfully associated with
better outcome (p= 0.9, Fig. 4d, Supplementary Fig. 4e, f and
Supplementary Table 5). To explain this difference, we hypo-
thesised that collagen at the IF, rather than collagen degradation
in the tumour-adjacent dermis, would be a better biomarker of
survival. Further analysis confirmed that collagen at the IF
strongly correlated to single cell invasion (Spearman R 0.5, p <
0.0001, Fisher Exact p = 0.002, Fig. 4e), MSS and progression-free
survival (PFS; Fig. 4f, Supplementary Fig. 4g, and Supplementary
Table 5). Furthermore, consistent with invasion data in Fig. 2j,
TCGA primary cutaneous melanomas expressing low COL1A1
showed improved survival (Fig. 4g and Supplementary Table 5).
These data suggest that primary melanomas invading in collagen-
poor matrices require new collagen synthesis in order to invade
successfully. To confirm this, we studied collagen at the IF spe-
cifically, in short-term and long-term survivors. We confirmed
melanomas arising at CSD sites with less collagen in the tumour-
adjacent dermis and shorter survival (MSS <5 years), increased
collagen deposition at the IF and tumour cell invasion (Fig. 4h, i
and Supplementary 5).
To further explore the association between collagen and
survival, we investigated if melanoma-associated fibroblasts
(MAFs) in primary melanomas increase collagen to sustain
invasion. For this, we extracted the gene expression signature
from single cell RNAseq37 and confirmed COL1A is expressed by
MAFs (Supplementary Fig. 4h). We then tested if increased
expression of MAFs in primary melanomas correlates with
outcome and were able to demonstrate that a higher expression of
MAF genes is associated with poor survival (Fig. 4j). Further-
more, we show that the expression of collagen genes specifically
within the MAF expression signature is what impacts survival, as
the MAF signature is not significantly prognostic in the absence
of collagen genes (Supplementary Fig. 4i and Supplementary
Table 5).
Solid cancers synthesise high amounts of ECM proteins and
COL1A1; and ECM remodelling promotes primary tumour
progression and metastasis40,41. Therefore, we designed a
tumour-agnostic approach to test the potential of COL1A1
expression as a biomarker for primary pan-cancer survival. This
revealed young and aged patients with primary cancers expres-
sing high levels of COL1A1 are at greater risk of death and have
shorter PFS (Fig. 4k, l and Supplementary Fig. 4j–l).
Discussion
Multiple in vivo studies confirm UVR cooperates with onco-
genic mutations to increase the incidence and penetrance of
disease5,42. However, whether UVR exposure affects the odds of
survival has not been comprehensively investigated, and there
are contradictory studies finding sun exposure inferred by
anatomic site8, history of sunburn9,18 or the presence of UVR-
induced dermal degradation6,10 can affect outcome. The
majority of melanoma deaths affect the elderly13, and age is
strongly associated with accumulated sun exposure7. We
investigated if pre-existing UVR damage affects melanoma
Fig. 2 Low collagen quantity and integrity decrease melanoma cell invasion. a Mean and individual b melanoma spheroid invasion (Kruskal–Wallis with
Dunn’s multiple comparison tests *p= 0.0317, ****p < 0.0001, n= 8 replicate spheroids for three cell lines across two-independent experiments), and
c single cell invasion (Skmel28) (Kruskal–Wallis with Dunn’s multiple comparison tests ****p < 0.0001, n= 9 independent measurements over two
experiments) in different collagen concentrations. d Representative images of spheroid and melanoma single cell invasion, top: Hoechst (inverted), bottom:
invading cells (blue). e A375 melanoma invasion H&E (scale bar: 10 µm) and f single cell invasion in organotypic dermal collagen HFF and UV-HFF
constructs (two-sided Mann–Whitney U *p= 0.0485, ns not significant, data represents 12 fields of view across two-independent experiments). g Mean
and individual hmelanoma invasion (Kruskal–Wallis with Dunn’s multiple comparison tests ***p < 0.001, ****p < 0.0001, n= 8 replicate spheroids for three
cell lines across two-independent experiments), and i melanoma single cell invasion (Kruskal–Wallis with Dunn’s multiple comparison tests *p= 0.0426,
n= 7 independent measurements over two experiments) by collagenase I concentration. j Representative images of spheroid and single cell invasion, top:
Hoechst (inverted), bottom: invading cells (blue). k Melanoma spheroid invasion by adult patient fibroblast secretome, MMP1 levels (two-sided Pearson
correlation, red: Sk-mel-28 R=−0.39 p= 0.1, blue: A375 R=−0.21 p= 0.4, data represent eight independent cell lines measured in duplicate) and l by
COL1A1 relative expression (RE) in fibroblasts (two-sided Pearson correlation, red: Sk-mel-28 R= 0.57 p= 0.02, blue: A375 R= 0.32 p= 0.2, data
represent eight independent cell lines measured in duplicate). Error bars: standard error of the mean (bar).
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survival, and found low collagen quantity and integrity limit
melanoma invasion. UVR damage to fibroblasts degrades col-
lagen and the ECM, delaying melanoma progression. We con-
firmed our in vitro results, showing that in aged primary
cutaneous melanomas, single tumour cells invading the dermis
and collagen at the IF robustly predict poor survival. Para-
doxically, this study finds UVR damage to the dermis destroys
collagen, limiting invasion and improving outcome, unless
tumours increase the production of collagen at the IF, providing
the structural support for melanoma invasion. Together with
recent work showing UVR-protected aged fibroblasts38 and
ECM39 drive melanoma metastasis, this study strongly impli-
cates the physical composition and structure of the aged
tumour microenvironment, as key to primary melanoma
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progression. We therefore infer from these joint studies that
excessive old age mortality particularly affects patients with
tumours arising at anatomic sites with preserved dermal col-
lagen, or sun-protected skin. In contrast, UVR damage modifies
the dermis and decreases collagen content as we age. As mel-
anomas arising in collagen-poor, sun-damaged skin require
collagen to invade, we show that collagen deposition at the
invasive edge of the tumour is an independent, robust bio-
marker of survival. Conveniently, the deposition of collagen at
the IF can be scored simply from haematoxylin and eosin
stains, making this an ideal biomarker.
Melanomas with more UVR damage accumulate more muta-
tions and neoantigens, possibly eliciting stronger immune
responses43,44. However, we show a proportion of UVR mela-
nomas have a better prognosis due to collagen degradation,
independently of the mutation burden, tumour and stromal cell
immunogenicity, which should be considered when evaluating
responses to adjuvant immunotherapy. One possibility is to
prioritise adjuvant care according to single cell invasion, collagen
at the IF and risk of death. Supporting this rationale, recent
evidence shows collagen density modifies the immune milieu of
breast cancers, limiting T-cell responses45.
The accumulation of a collagenous ECM, increasing stiffness,
leads to poor prognosis and lack of response to therapies in
other cancers40. Alterations of the ECM dynamics are a hall-
mark of cancer, able to deregulate cancer and stromal cells46,47,
promote cell transformation and the pro-metastatic niche,
which becomes rich in vasculature and tumour-promoting
inflammation48. Clinical trials with drugs inhibiting MMPs and
limiting ECM remodelling have yielded negative and sometimes
deleterious results. One possible explanation for this failure,
based on our study in melanoma, is that inhibition of
collagen degradation may support tumour invasion. Collagen
can drive cancer cell de-differentiation19,49–51 and is often
found in areas of active epithelial cancer invasion, facilitating
migration50,52.
Ageing is associated with less collagen deposition, more
degradation and higher overall cancer incidence and mortality in
multiple tissues, including skin. One possibility is the collagen
decrease in aged tissue, which could lead to less aggressive cancer,
is offset by a decrease in ECM structural fitness, collagen and
matrix organisation, and pro-tumourigenic signalling with age41.
This work suggests new collagen synthesis by the TME is a critical
regulator of aged primary melanoma progression, a feature that
could drive poor outcome in other aged cancers. Critically, our
data shows collagen expression is associated in multiple solid
epithelial and non-epithelial primary tumours with shorter PFS in
all ages, possibly due to direct modulation of invasion.
Methods
Cell lines and patient fibroblasts. HFF were purchased from ATCC (ATCC
SCRC-1041). Three melanoma cell lines, Sk-mel-28 (ATCC HTB-72), Sk-mel-3
(ATCC HTB-69) and A375 (ATCC CRL-1619) were purchased from ATCC. All
cell lines were cultured in DMEM (Gibco, 41966-029) supplemented with 10% FCS
(Sigma Aldrich, F7524), 1× Glutamax (Gibco, 35050061), 100 U/ml penicillin and
streptomycin (Gibco, 15140122) and 1 mM sodium pyruvate (Gibco, 11360070).
Cells lines were cultured at 37 °C in 5% CO2 with medium replaced as required.
Cell lines were tested every fortnight for mycoplasma using LookOut Mycoplasma
PCR Detection Kit (Sigma Aldrich, MP0035). Cell line identity was confirmed
using STR profiling.
Patient fibroblasts. A prospective cohort of patient fibroblast cultures was
established from redundant skin acquired during surgical resection of the wide
local excision of healthy skin from melanoma patients treated at the tertiary referral
cancer Christie hospital. Ethical approval to establish cell lines was granted by the
local Biobank committee (17_AMVI_01), which required signed informed consent
from all participants. The hypodermis of whole skin samples was removed scraping
with a scalpel, and the residual specimen was incubated overnight in Dispase
(Gibco, 17105-041) at 4 °C to separate the epidermis and dermis. The dermis was
digested in collagenase I (Gibco, 17018029) in DMEM (without FCS) at 37 °C for
6 h, and then filtered through 70 µm filter to remove the residual debris. Dermal
cells were spun at 300 × g and resuspended in DMEM 20% FCS, cultured in
DMEM 20% FCS until they became confluent and stained for vimentin (Abcam,
ab92547). The level of solar elastosis of the redundant skin collected was scored
using previously well-established methods32.
Whole-exome sequencing of patient fibroblasts. Whole-exome sequencing of
fibroblasts was performed by Novogene (Novogene (UK) Company Ltd.). Exome
capture was performed with the SureSelect Human All Exon v6 kit (Agilent) and
sequenced on the Illumina HiSeq platform. Sequencing reads were trimmed using
Trimmomatic53, aligned to the hg38 reference genome using BWA54, and duplicate
reads were marked using Picard Tools (http://broadinstitute.github.io/picard).
Somatic mutations were called using the Varscan 2 pipeline55. Identified somatic
variants were annotated using Variant Effect Predictor56 and variants present in
dbSNP (but not in the COSMIC database) were excluded.
Lentiviral shRNA transfection. Knockdown of MMP1 expression in HFF cells
was performed using shRNA Lentiviral Particles (Santa Cruz Biotechnology) and
siGENOME siRNA (Horizon Discovery). For MMP1 shRNA knockdown
MMP1 shRNA (h) lentiviral particles (sc-41552-V) were used alongside a
scramble control, control shRNA lentiviral particles A (sc-108080) and copGFP
Fig. 3 Inhibition of MMP1 restores melanoma invasion. a Fold change in MMP1 relative expression (RE) in chronically UVR-treated adult patient
fibroblasts compared to untreated isogenic cell lines, noCSD no chronic sun damage, pink, CSD chronic sun damage, blue (two-sided Mann–Whitney
U **p= 0.0022, ns not significant, data represent two samples per condition quantified in triplicate). b Fold change in secreted MMP1 in chronically UV-
treated adult fibroblasts compared to untreated isogenic cell lines, noCSD no chronic sun damage, pink, CSD chronic sun damage, blue, (two-sided
Mann–Whitney U *p= 0.0286, data represent two samples per condition quantified in triplicate). c Melanoma spheroid invasion in noCSD and isogenic
noCSD-UV fibroblast secretomes in the presence of Batimastat or DMSO vehicle, (two-sided Mann–Whitney U **p= 0.0011, *p= 0.0104, data represents
eight replicate spheroids measured across two-independent experiments per condition). d Melanoma spheroid invasion in CSD and isogenic CSD-UV
fibroblast secretomes in the presence of 8 nM Batimastat or DMSO vehicle, (two-sided Mann–Whitney U, ns not significant). Data represents eight
replicate spheroids measured across two-independent experiments per condition, box plots represent 25th to 75th percentiles with median, whiskers
represent minimum and maximum values. e Representative images of collagen degradation in shCtrl-HFF, shCtrl-UV-HFF, shMMP1-HFF and shMMP1-UV-
HFF fibroblasts. Green: intact DQ collagen; red: phalloidin; blue: Hoechst. Size bars: 20 µm. f Fold change in collagen degradation of shCtrl-HFF and
shMMP1-HFF (pink), and their isogenic chronic UVR cell lines shCtrl-UV-HFF and shMMP1-UV-HFF (blue), (two-sided Mann–Whitney U ***p= 0.0007, ns
not significant, n= 149 scores across two biologically independent cell lines per condition). g Immunofluorescence of fibronectin fibres in decellularised
shCtrl-HFF, shCtrl-UV-HFF, shMMP1-HFF and shMMP1-UV-HFF-derived ECM, colour coded for orientation of fibre, cyan represents mode, red ±90°, scale
bar: 25 µm. h Quantification of fibre alignment distribution in shCtrl-HFF, shCtrl-UV-HFF, shMMP1-HFF and shMMP1-UV-HFF-derived ECM, data
represents z-stacks of three fields of view per sample. i Quantification of invading melanoma cells into organotypic dermal collagen constructs made with
shCtrl-HFF and shMMP1-HFF (pink), and isogenic chronic UVR cell lines shCtrl-UV-HFF and shMMP1-UV-HFF (blue), (two-sided Mann–Whitney U *p=
0.0272, ns not significant, data represents >8 fields of view for two-independent experiments in biologically independent cell lines), scoring was performed
on duplicate constructs counting in at least five fields of view per cell line. j Representative images of A375 invasion into organotypic constructs stained
with H&E (scale bar: 10 µm). Error bars represent standard error of the mean (bar).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-22953-z ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:2742 | https://doi.org/10.1038/s41467-021-22953-z | www.nature.com/naturecommunications 7
control lentiviral particles (sc-108084) were used to measure transduction effi-
ciency. A total of 5 × 104 cells were cultured in cell culture media with 5 ug/ml
polybrene (Santa Cruz Biotechnology, sc-134220). Lentiviral particles were
added to cells and incubated overnight. Media containing lentiviral particles and
polybrene was removed and incubated in DMEM overnight before preforming
selection of transfected cells using increasing concentration of puromycin over
72 h. Once cells were stably growing in puromycin, cells were cultured as normal
in DMEM. For MMP1 siRNA siGENOME human MMP1 siRNA (D-005951-02-
0002) and non-targeting siRNA #4 (D-001210-04-05) were used with Dhar-
maFECT 1 transfection reagent (Horizon Discovery, T-2001-02), according to
manufactures protocols, with a final siRNA concentration of 25 nM. Knockdown
of MMP2 was performed with MMP2 shRNA (h) lentiviral particles (sc-29398-
V) as above. Knockdown of all gene expression was validated by qPCR and
western blot.
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UV treatment and CSD model. Cell lines were treated with UVB using a Bio-Sun
UV irradiation system (Vilber Loumat). For chronic treatment the dose 100 J/m2
was used as it represents a physiologically relevant dose of UVB that would
penetrate the dermis between 1 and 5 minimal erythema dose57. To create isogenic
in vitro chronic UV-damaged UV-HFF and shMMP1-UV-HFF, noCSD-UV, CSD-
UV cell lines, 1 × 106 HFF, shMMP1-HFF or patient dermal fibroblasts were cul-
tured in 100 mm dishes in phenol-free DMEM 1% FCS. All fibroblasts were treated
every 24 h with 100 J/m2 UVB for eight consecutive days. Following the UV
treatments, the medium was changed to DMEM 10% FCS and cultured for 1 week.
Isogenic untreated control cell lines (HFF, shMMP1-HFF, noCSD and CSD) were
cultured in identical conditions without the UVB treatments. Each HFF condition
was created in biological duplicates.
Secretome collection. To collect secretomes 1 × 106 cells were plated in a 100 mm
dish and cultured for 72 h in DMEM without FBS to limit cell proliferation.
Secretomes were collected in duplicate, aliquoted and stored at −80 °C until used.
Batimastat treatment. MMP inhibitor Batimastat (Sigma Aldrich, SML0041) was
resuspended in DMSO at 15 mg/ml and a stock was diluted to 1 mM. Batimastat
was added to fibroblast secretomes to a final concentration of 8 nM in secretome
volume and control secretomes had equal volume of DMSO added as a vehicle
control.
RNA-sequencing data analysis. RNA-seq data from ENA project PRJEB13731;
also at https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-4652/ were
downloaded. Data are single-end RNA-seq from short-term cultivated fibroblasts
sequenced on an Illumina HiSeq 2000 sequencer. Two samples had been obtained
from each individual from different locations (B= buttock, not UV exposed; S=
shoulder, UV exposed). Sequencing reads were trimmed53 and aligned to the
human reference genome (GRCh37) using STAR58. Production of analysis-ready
reads was conducted according to the Broad Institute Best Practices pipeline
(https://gatkforums.broadinstitute.org/gatk/discussion/3892/the-gatk-best-
practices-for-variant-calling-on-rnaseq-in-full-detail) using GATK v3.2 (http://
www.broadinstitute.org/gatk). Somatic single nucleotide variants (SNV) in each
patient matched sample in regions annotated as protein-coding only (based on
Ensembl Homo_sapiens.GRCh37.87) were identified with the mutation calling
algorithm MuTect v1, using the other sample as the comparator59. Identified
somatic variants were annotated using Variant Effect Predictor and common
variants were excluded.
COSMIC mutational signatures v2 (https://cancer.sanger.ac.uk/cosmic/
signatures_v2) were identified using the MutationalPatterns60 package (version
1.8.0) in R (version 3.5.1, RStudio v1.2.5001, RStudio Inc). Differential expression
analysis was performed using the DESeq2 package (version 1.22.2, ref. 61) in R
(version 3.5.1). Reads counts of genes were filtered for genes expressed in
fibroblasts by removing any gene with <100 counts across all samples. For pathway
enrichment analysis genes that were significantly differentially expressed in by
signature 7 mutation count (false discovery rates (FDR) p value < 0.1) were
compared against the Reactome Database62 using the Molecular Signatures
Database v7.0 (Msigdb, Broad Institute, https://www.gsea-msigdb.org/gsea/msigdb/
index.jsp).
Fibroblast extracellular matrix production. Following ECM construction63 cell
culture dishes were coated with 0.2% sterile gelatin (Sigma Aldrich, G1393), fixed
with 1% glutaraldehyde and quenched with 1M glycine in PBS (pH 7). Fibroblasts
were cultured on gelatin plates in normal 10% FCS DMEM containing 50 µg/ml
ascorbic acid for 8 days. Cells were lysed with extraction buffer (20 mM NH4OH
and 0.5% Triton X-100 in PBS), and washed thoroughly with PBS containing
calcium and magnesium. DNA was digested with 10 µg/ml DNase I (Roche,
04716728001) and washed. For mass spectrometry the ECM was collected with a
lysis buffer (100 mM TrisHCl pH 7.5, 4% SDS and 100 mM DTT) and collected
with scraper, sonicated and boiled at 95 °C, followed by centrifugation (16,000 × g,
15 min) and collection of the supernatant, stored at −80 °C until use.
Immunofluorescence and ECM fibre analysis. For immunofluorescence and
ECM fibre analysis, fibroblasts derived matrices constructed as above on glass
coverslips, after DNase digestion matrices, were fixed in 4% paraformaldehyde
(PFA), blocked 5% BSA TBS-T (5% BSA in 1× Tris-buffered saline and 0.1%
Tween 20) for 1 h, and stained for Fibronectin64. Primary antibody to fibronectin
(1:200, F3648, Sigma Aldrich, 5% BSA TBS-T) and secondary goat anti-rabbit
Alexa Fluor 488 (1:2000, Thermo Fisher) were incubated for 1 h at room tem-
perature. The immunofluorescence imaging was performed using a Carl Zeiss
LSM880 inverted confocal microscope with 63× NA 1.4 oil objectives lens con-
trolled by ZEN black software. The images were acquired with 488 nm illumination
laser line from an Argon laser (Lasos) and the emission spectrum range from 500
to 550 nm collected with a PMT detector (Zeiss). Z-series optical sections were
collected with a step size of 0.5 micron driven by Piezo stage (Zeiss). Fibre
orientation analysis was performed using ImageJ OrientationJ plugin64,65. Maximal
projection of three individual z-stacks for each condition were analysed.
Mass spectrometry sample preparation and analysis. ECM protein lysates were
separated on a 4–12% gradient NuPAGE Novex Bis-Tris gel (Life Technologies).
Each sample was cut into three slices and in-gel digested with trypsin
(Promega)66,67. Digested peptides were desalted by C18 StageTip68, acetonitrile was
removed by speed vacuum, and peptides were resuspended in 1% trifluoroacetic
acid and 0.2% formic acid. Peptides were injected into an EASY-nLC (Thermo
Fisher Scientific) coupled online to an Orbitrap Fusion Lumos mass spectrometer
(Thermo Fisher Scientific), separated using a 20 cm fused silica emitter (New
Objective) packed in house with reversed-phase Reprosil Pur Basic 1.9 μm (Dr
Maisch GmbH) and eluted with a flow of 300 nl/min from 5 to 30% of buffer (80%
ACN and 0.1% formic acid), in a 90 min linear gradient. MS raw data were
acquired using the XCalibur software (Thermo Fisher Scientific). MS raw files were
processed using MaxQuant software69 (version 1.6.3.3) and searched against the
human UniProt database (release 2016_07, 70,630 sequences), using the Andro-
meda search engine70 with the following settings: the parent mass and fragment
ions were searched with an initial mass deviation of 4.5 and 20 p.p.m., respectively.
Carbamidomethyl (C) was added as a fixed modification and acetyl (N-term) and
oxidation (M) as variable modifications. The minimum peptide length was set to
seven amino acids and a maximum of two missed cleavages, and specificity for
trypsin cleavage were required. The FDR at the protein and peptide level were set
to 1%. The LFQ setting was enabled for protein quantification71. Razor and unique
peptides were used for quantification. Perseus software72 (version 1.6.2.2) was used
for statistical analysis. Data were filtered to remove potential contaminants, reverse
peptides that match a decoy database and peptides only identified in their modified
Fig. 4 Low collagen correlates with low invasion and improved outcome in aged melanoma patients. a H&E top panel: primary cutaneous melanoma and
inset (box) with single cell invasion (arrows) in a collagen-rich dermis with no chronic sun damage (noCSD), collagen: red (scale bars left: 4000 µm, right:
400 µm). Lower panel: melanoma in a collagen-poor dermis with chronic sun damage (CSD) and inset (box), no single cell invasion; collagen: red (scale bars
left: 3000 µm, right: 300 µm). b Histogram displaying melanoma invasion at the invasive front (IF) in noCSD and CSD melanomas (B and C cohorts, n= 170,
two-sided Fisher exact test, p= 2.25 × 10−5). c Kaplan–Meier of melanoma-specific survival (MSS) in prominent (high, red) and minimal (low, blue)
melanoma invasion at the IF (two-sided log-rank test, B and C cohorts, n= 167). d Kaplan–Meier of MSS in melanoma invading in CSD (blue) and noCSD
(pink) dermis (two-sided log-rank test, B and C cohorts, n= 331). e Histogram displaying collagen quantity at the IF in highly invasive (red) and minimally
invasive (blue) melanoma (C cohort, n= 89, two-sided Fisher exact test, p= 0.002). f Kaplan–Meier of MSS by collagen quantity at the IF (two-sided log-
rank test, C cohort, n= 62). g Kaplan–Meier of MSS by COL1A1 expression in aged (>54) primary cutaneous melanoma (two-sided log-rank test, TCGA
cohort, n= 80). h Fold increase in collagen deposition at the IF of noCSD and CSD melanomas by MSS (two-sided Mann–Whitney U ***p= 0.0009 C
cohort n= 90). Error bars represent standard error of the mean (bar). i H&E top panel: left CSD melanoma, middle: from box inset: tumour-adjacent dermis;
right: from dashed box inset: IF (dashed line, scale bars: 2000, 300, 300 µm). Bottom: left CSD melanoma, middle: from box inset: tumour-adjacent dermis;
right: from dashed line box inset: IF between dashed lines, arrows: melanoma invasion, (scale bars: 2000, 70, 200 µm, n= 90). j Kaplan–Meier of MSS by
melanoma-associated fibroblast (MAF) signature score in aged (>54) primary cutaneous melanoma cohort (two-sided log-rank test, TCGA cohort, n= 80).
k Hazard ratio (centre) and 95% CI (bars) for OS, and PFS (l) in two-sided univariate Cox regression of COL1A1 expression by cancer type in PANCAN
TCGA, p values unadjusted. (ACC n= 79, adrenocortical carcinoma, BLCA n= 407, bladder urothelial carcinoma, CESC n= 304, cervical and endocervical
cancers, COAD n= 448, colon adenocarcinoma, KICH n= 65, kidney chromophobe, KIRC n= 533, kidney renal clear cell carcinoma, KIRP n= 289, kidney
renal papillary cell carcinoma, LGG n= 514, brain lower grade glioma, LUAD n= 506, lung adenocarcinoma, MESO n= 86, mesothelioma, PAAD n= 178,
pancreatic adenocarcinoma PRAD n= 497, prostate adenocarcinoma, STAD n= 409, stomach adenocarcinoma). Risk tables for all Kaplan–Meier analyses
in Supplementary Data 2.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-22953-z ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:2742 | https://doi.org/10.1038/s41467-021-22953-z | www.nature.com/naturecommunications 9
form. LFQ intensities were transformed by log2. A two-sample t test was used to
determine significantly regulated proteins, with the permutation-based FDR ≤ 0.05
and S0= 0.1 being considered significant.
Atomic force microscopy. For imaging purposes, the ECMs prepared as above
were fixed with 2% PFA and stored with PBS containing 1% penicillin/strepto-
mycin at 4 °C. A day prior to imaging, the dishes were washed with distilled water
five times to wash off any salt and then air dried overnight. Samples were imaged
by intermittent contact mode in air using a Bruker ScanAsyst 9.1. The probe was
auto-tuned using Nanoscope software (version 1.4). Images were taken at 10 × 10
μm and 2 × 2 μm area at least two sites. Data were processed using Nanoscope
analysis software 1.4 prior to image export. The roughness (Rq) values were
determined using the software. Roughness is the root mean square average of the
image and is calculated based on the height difference per pixel along the sample
length. Rq is used to study the surface topography of various nanostructures28,29.
Rq provides a quantitative measure of fibril organisation in dermis and could
possibly suggest the integrity of matrix30.
Collagen degradation assay. To quantify the degradation of collagen in different
fibroblast cell lines a collagen degradation assay based on ref. 73 was used. DQ
collagen, type I from bovine skin, fluorescein conjugate (Invitrogen, D12060) was
used to coat the wells of a 96-well plate for 1 h at 37 °C and quenched with 20 mM
glycine for 5 min. Next, fibroblasts were plated at a concentration of 2.5 × 103/well
and incubated in normal culture conditions for 18 h. Cells were then fixed with 4%
PFA for 20 min at room temperature, permeabilised with Triton 0.1% X-100 for 5
min at room temperature and stained with Alex Fluor 546 Phalloidin (Invitrogen,
A22283) 1:2000 for 1 h and DAPI (Invitrogen, D3571) 1:2000 for 15 min. Wells
were imaged with the Opera Phenix High Content Screening System (Perkin
Elmer, Inc.), and collagen degradation was quantified by either measuring the area,
where DQ collagen had been degraded and normalising to cell number (DAPI) or
by scoring of images by two-independent assessors (one of them blinded), scoring
the intensity of collagen degradation as low (1: peri-cytoplasmic ring of collagen
degradation <1/4 of the cytoplasmic diameter); medium (2: peri-cytoplasmic ring
of collagen degradation ~1/3 of the cytoplasmic diameter) or high (3: peri-
cytoplasmic ring of collagen degradation ~1/2 of the cytoplasmic diameter; Sup-
plementary Fig. 3a). To establish the ratio of degradation between shCtrl-HFF and
shCtrl-UV-HFF, and shMMP1-HFF and shMMP1-UV-HFF cells, we generated a
score (H) of collagen degradation for each condition:
H ¼Σ low intensity images ´ 1 þ medium intensity images ´ 2 
þ high intensity images ´ 3  total images
We scored, 150 images for shCtrl-HFF, 147 images for shCtrl-UV-HFF, 150
images for shMMP1-HFF and 146 images for shMMP1-UV-HFF fibroblasts. The
ratios were established as: ratio shCtrl-UV-HFF/shCtrl-HFF=H-score shCtrl-UV-
HFF/H-score shCtrl-HFF, and ratio shMMP1-UV-HFF/shMMP1-HFF=H-score
shMMP1-UV-HFF/H-score shMMP1-HFF.
MMP1 ELISA. MMP1 in the secretome of cell lines was quantified with a MMP1
Human ELISA Kit (Thermo Fisher Scientific, EHMMP1), according to manu-
facturer’s protocol. Secretomes collected from cells were diluted 1:10 and standards
and samples were measured in triplicate. Samples were incubated on plate over-
night at 4 °C. Absorbance measured on a Spectra Max M5 plate reader (Molecular
Devices).
Quantitative PCR. RNA was collected in duplicate from 1 × 106 cells lysed in
TRIzol Reagent (Invitrogen, 15596018) after secretomes were collected. The aqu-
eous phase of phenol–chloroform separation was collected and RNA extracted
using RNeasy Mini Kit (Qiagen, 74104). Concentration was determined with the
Qubit RNA HS Assay (Invitrogen, Q32852) and 500 ng RNA was reverse tran-
scribed to cDNA using TaqMan Reverse Transcription Reagents (Thermo Fisher,
N8080234), and diluted 1:20 in nuclease free water. Genes were quantified by qPCR
using TaqMan Gene expression assays and Fast Mastermix on a QuantStudio
3 system. GAPDH (Hs02758991_g1) and ACTB (Hs01060665_g1) were used as
housekeeping genes. MMP1 (Hs00899658_m1), COL1A1 (Hs00164004_m1) and
COL1A2 (Hs01028956_m1) were quantified and normalised to the geometric mean
of both housekeeping genes and relative expression calculated using 2−Δct.
Western blots. Intracellular protein was extracted from cells using the NucBuster
Protein Extraction Kit (Merck, 77183) and quantified using Pierce BCA Protein
Assay Kit (Thermo Fisher Scientific, 23225). A total of 40 µg of cytoplasmic protein
was diluted in laemmli buffer (Bio-Rad, 1610747) with beta-mercaptoethanol,
denatured at 95 °C for 5 min and loaded onto Mini-PROTEAN TGX Gels (Bio-
Rad, 4568084). Samples were transferred to nitrocellulose membranes using the
TransBlot Tubro system (Bio-Rad, 170–4270) and protein visualised with Ponceau
Stain (G-Biosciences). Membranes were blocked in 5% BSA TBS-T (5% BSA in 1×
Tris-buffered saline and 0.1% Tween 20) for 1 h and incubated with primary
antibodies overnight in 5% BSA TBS-T (MMP1 1:1000 ab137332, MMP2 1:1000
D4M2N Cell Signalling, B-actin 1:10,000 ab8226, Abcam). Membranes were
washed with TBS-T and incubated in secondary antibodies (Dnk pAb to Rb IgG
IRDye 680RD, ab216779, Goat pAb to Ms IgG IRDye 800CW, ab216772, Abcam)
for 1 h at room temperature. Membranes were visualised using the Odyssey CLx
system (Licor).
Melanoma spheroid invasion assay. Melanoma cell lines were cultured in U-
bottom 96-well plates (Brand, 781900) at 1 × 103 cells per well, spun at 200 × g, and
spheroids allowed to form over 72 h. Culture media was removed from the wells
and 100 µl collagen (PureCol, Advanced BioMatrix, 5005-100ML) added to the
wells. Plates were briefly spun for 15 s at 200 × g and incubated at 37 °C for 1 h to
set collagen. For concentration gradient collagen was diluted to 0.25, 0.5, 1, 1.5, 2 or
2.5 mg/ml in phenol-free DMEM without FCS. For degraded collagen invasion
collagen was diluted to 1.5 mg/ml in phenol-free DMEM containing collagenase I
(Gibco) to final concentration in the collagen of 0.5, 1, 5 or 10 µg/ml. For invasion
using fibroblast secretomes collagen was diluted to 1.5 mg/ml using secretome
collected from various fibroblast cell lines instead of DMEM. Spheroids were
allowed to invade over 72 h and light microscopy photographs were taken. Images
were analysed to quantify the invasive area around the spheroid by creating a
layered mask for the spheroid core and invasive area, and quantifying the invasive
area as a percentage of the total size of the spheroid in ImageJ software (1.53c). For
single cell invasion analysis, spheroids in the above conditions were imaged using
an Opera Phenix (Perkin Elmer) with a 5× (0.16 NA) lens. Spheroids were stained
with Hoechst 33342 for 1 h prior to imaging. Stacks of images were acquired
through the full depth of the spheroids, and images were analysed using Columbus
software (Perkin Elmer). A custom analysis pipeline was used to detect individually
invading cells. In brief, a maximal intensity projection of the Hoechst stain was
processed (Flatfield correction: Basic, Guassian blur: 2px) was used to determine
the perimeter of the spheroid, and nuclei were detected in the remaining portion of
the image. Experiments with varying levels of collagen matrices or collagenase were
repeated, and confirmed by an independent laboratory, blinded for matrix
composition.
Organotypic 3D invasion models. Melanoma invasion through fibroblast-
modified collagen was assayed using a protocol adapted from Timpson74. Briefly,
equal numbers of HFF, UV-HFF, shMMP1-HFF and shMMP1-UV-HFF fibro-
blasts were mixed with collagen I, rat tail (Corning, 354236) and cultured in 35 mm
culture dishes. Collagen discs were allowed to contract until they fit in a 24-well
plate. Cell suspensions of Sk-mel-28 and A375 at 4 × 104 cells/ml were plated on
top of each collagen disc in duplicate for each fibroblast condition. Cells and
collagen were cultured as normal for approximately 5 days. Collagen discs were
then transferred to Falcon 3.0 µm high density PET membrane (Corning, 353092)
in Falcon six-well Deep Well TC-treated Polystyrene Plates (Corning, 355467) to
create an air/liquid interface to drive melanoma invasion into collagen. After
10 days constructs were fixed in 4% PFA, and embedded in paraffin and stained
with H&E and stained for Fibronectin with FN1 antibody (F3648, Sigma Aldrich).
For each construct, the number of cells invading into the collagen was counted in at
least five different fields of view under light microscopy, by two-independent
scorers. Leica SCN400 was used for whole slide imaging alongside ImageScope
software v12.3 (Leica Microsystems).
Second-harmonic generation imaging. Second-harmonic generation imaging of
collagen in 3D organotypic models was performed using a Leica SP8 upright
confocal microscope with 25× NA 0.95 water objectives controlled by Leica LAS X
software. The images were acquired with 880 nm illumination laser line from
MaiTai Ti:Sapphire laser (Spectra Physics) and HyD-RLD detector installed 440/
20 nm filter cube (Leica), also used 483/32 nm filter (Leica) collecting auto-
fluorescence signals at the same time. Z-series optical sections were collected with a
step size of 1 micron driven by SuperZ galvo stage (Leica). Collagen was quantified
in ImageJ by measuring the mean signal intensity of z-stack sum projections in
three equal sized areas across three fields of views for each collagen disc.
Clinical samples. Three international patient cohorts of primary cutaneous mel-
anoma were used in this paper. The A cohort (n= 31), the B cohort (n= 222) and
the C cohort (n= 113). (A: Salford Royal NHS Foundation Trust, UK, B: Instituto
Valenciano de Oncología, Valencia, Spain, C: Aix-Marseille University Hospital,
France). Comprehensive clinical outcome was available for the B and C cohorts;
and was collected prospectively at both institutions. All clinical and pathological
information assessed complied with all relevant ethical regulations for work with
human participants in the UK, Spain and France: Salford cohort A: Local ethics
and UK NHS REC regulation approval, IRAS 16/LO/2098 (16/SW/0323); no
patient signed consent required; Spanish cohort B: Internal Review Board of the
Instituto Valenciano Oncología in Valencia, and verbal informed consent was
obtained from all patients who were alive at the time of the study; French cohort C:
Internal Review Board of the Comite de Protection des Personnes Sud Médi-
terranée and Aix-Marseile University Hospital approval, and signed informed
consent was obtained. The analyses were performed by at least two observers
(cohort A: observer A.V. and L.M.; cohort B: V.T., E.N. and A.V.; cohort C: A.V.
and L.M.). Discrepancy in cohorts A and B were jointly reviewed and consensus
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agreed. There was high kappa interobserver agreement in cohort C (>0.65), and all
scores were done blinded for clinical outcome.
Comprehensive clinical outcome was available for the B and C cohorts; and was
collected prospectively at both institutions. The correlation between solar elastosis
and invasion of melanoma cells at the IF was done in the A cohort in patients with
invasive primary melanoma, where a distinct vertical growth was determined in
patients aged ≥55 at the time of diagnosis. The correlation and histological
assessments of the B and C cohorts were done in primary cutaneous melanomas of
patients aged ≥55 at the time of diagnosis with Breslow ≥1 mm. The clinical
characteristics of the cohorts are described in Supplementary Table 4.
Histological and clinical sample analysis. The histological assessment of primary
cutaneous melanomas of the A, B and C (20%) cohorts, from three international
centres, was performed by at least two observers (cohort A: observer 1 and 2;
cohort B: 1, 3 and 4; cohort C: 1 and 2). Discrepancy in cohorts A and B were
jointly reviewed and consensus agreed. There was high interobserver agreement in
cohort C (>0.65), and all scores were done blinded for clinical outcome. The
survival analyses were performed by members of the team who did not score
histological variables. We included all samples with sufficient material to assess the
tumour body, IF and tumour-adjacent skin. Recurrent tumours were excluded.
Non-primary melanomas were excluded. Solar elastosis was scored as described by
Landi32 et al., and cutoffs for low, moderate and high solar elastosis; or CSD
noCSD established from the original Landi categories. Landi et al. established a
scoring system for the degree of solar elastosis from absent to severe using an 11-
point score, from 0 to 3+. To generate binary categories, cases are classified as
bearing no chronic sun damage (noCSD), for scores between 0 and 2−, or CSD for
scores 2 to 3+. Cutoffs for absent (range 0, 0+), low (range 1− to 1+), moderate
(range 2− to 2+) and high (3− to 3+) were established from the same range75. We
assessed the inter-reliability of the binary CSD classification between two scorers
using the kappa statistic, which showed 0.75 concordance for the B cohort
(weighted kappa= 0.75, 95% CI= 0.69–0.79).
The proportion of melanoma cell invasion at the IF in the dermis was scored in
categories. We assessed the front of the melanoma component in the dermis that is
in direct contact with the dermal matrix, and scored 0/1: no invasion/minimal
invasion: <5% of cells in contact with the dermis are actively invading the matrix,
detaching from the IF of the melanoma; 2: low invasion: 5–25% of melanoma cells
at the IF detaching from the tumour body; 3: moderate invasion: 25–50% of the IF
is actively detaching from the main VGP and entering deeper structures; 4: high
invasion: the majority of cells at the IF are independently interacting with the
matrix, detached from the body of the tumour. Binary categories were then
generated with low invasion (scores 0–2) and high invasion (3–4), a decision taken
before performing survival analyses. We assessed the inter-reliability of the
invasion score binary classification between two scorers using the kappa statistic,
which showed 0.7 concordance for the C cohort (weighted kappa= 0.7, 95% CI=
0.64–0.77).
The amount of collagen at the IF of the tumour and in tumour-adjacent skin
was scored from H&E slides (C cohort) according to abundance of distinctly
formed collagen bundles. Two-independent pathologists examined collagen on
H&E routine-stained sections of normal skin surrounding the melanomas and the
collagen adjacent/enveloping the IF of the tumour in the dermis at 100–200×
magnification. The following scoring system was used: collagen absent or low (1):
when fully formed collagen bundles were rare, and the visible collagen was
distributed in haphazard smaller fragments or unidentifiable in an amorphous
deposit of elastotic material. Low collagen (2): when well-defined, undulating fibres
of normal dermal length collagen, are scarce, and a pattern of elastotic (fragmented
or aggregate) material predominates. Medium collagen (3): well-defined,
undulating and organised fibres coexist with aggregate elastotic material. High
collagen (4): well-defined fibres in organised disposition predominating, with
minimal or absent elastotic material interspersed between the tight bundles
(Supplementary Fig. 4m). We assessed the inter-reliability of the collagen score
classification between two scorers using the kappa statistic, which showed 0.78
concordance for the C cohort (weighted kappa= 0.78, 95% CI= 0.7–0.81). A
subset of samples in cohort A (n= 16), for which tissue was available, were stained
with trichrome of Masson to quantify collagen. We were unable to score the B
cohort IF due to Covid-19 international restrictions.
Statistical analysis. Data collection was performed with Microsoft Excel 2010 (64-
bit, Microsoft). For in vitro studies, statistical analysis was performed in GraphPad
Prism (version 7.01, GraphPad Software, Inc.). For comparisons between two
groups, Mann–Whitney tests were used and for comparisons between multiple
groups, Kruskal–Wallis with Dunn’s multiple comparison tests. A p value < 0.05
was considered significant, after correcting for multiple testing where necessary.
For human studies, statistical analysis was performed in R (version 3.5.1, RStudio
v1.2.5001, RStudio Inc). Association between categorical data was performed with
Fisher exact tests. Survival analysis was performed using survival (version 3.1–12)
and survminer (version 0.4.6) packages. For all clinical cohorts, MSS, overall
survival (OS) and PFS were calculated from time of diagnosis. Univariate grouped
survival analysis performed with Kaplan–Meier and log-rank tests, and multi-
variate analyses with Cox regression models, with evaluation of the proportional
hazard assumption. Gene expression (log2(x+ 1) normalised RSEM) and clinical
data from the TCGA SKCM and PANCAN data sets was accessed from the UCSC
Xena data portal (https://xenabrowser.net/datapages/). Samples were grouped into
COL1A1 high or low based on the expression relative to the median expression of
all samples. The MAF score for each sample was determined by calculating the
geometric mean of all genes in a published MAF signature37. High and low MAF
samples were classified based on the median signature score.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The RNA-seq data used in this study has been previously published and available from ENA
project PRJEB13731. The remaining data are available within the article, Supplementary
Information or available from the authors upon reasonable request. Source data are
provided with this paper.
Code availability
No custom codes or algorithms were used in the analysis of this study, and all analyses
packages and software are cited in the manuscript. R codes used are available from the
corresponding author upon request.
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